Kathryn Jean Boor

Board Director

Director

International Flavors & Fragrances Inc Sarepta Therapeutics, Inc.

Insider activity · 24 months0 buys1 saleCumulative net flow

Nov 24 · 0 buys · 0 salesDec 24 · 0 buys · 1 saleJan 25 · 0 buys · 0 salesFeb 25 · 0 buys · 0 salesMar 25 · 0 buys · 0 salesApr 25 · 0 buys · 0 salesMay 25 · 0 buys · 0 salesJun 25 · 0 buys · 0 salesJul 25 · 0 buys · 0 salesAug 25 · 0 buys · 0 salesSept 25 · 0 buys · 0 salesOct 25 · 0 buys · 0 salesNov 25 · 0 buys · 0 salesDec 25 · 0 buys · 0 salesJan 26 · 0 buys · 0 salesFeb 26 · 0 buys · 0 salesMar 26 · 0 buys · 0 salesApr 26 · 0 buys · 0 salesMay 26 · 0 buys · 0 salesJun 26 · 0 buys · 0 salesJul 26 · 0 buys · 0 salesAug 26 · 0 buys · 0 salesSept 26 · 0 buys · 0 salesOct 26 · 0 buys · 0 sales

Total declarations

Companies

▲ Purchases (0 ops.)

—

▼ Sales (2 ops.)

€281k

Latest filing published 05 Jun 2026 for Sarepta Therapeutics, Inc.. Read the official filing

Filing timeline

BuySale

Kathryn Jean Boor

Insider track record

Disclosed buys

Disclosed sells

Not enough buy signals with a settled T+90 horizon to measure a track record yet.

Signal history

Kathryn Jean Boor: trading record in brief

This profile gathers the share dealings of Kathryn Jean Boor across 2 companies, led by Sarepta Therapeutics, Inc. and International Flavors & Fragrances Inc. The record holds 8 filings, for trades running from 6 May 2021 to 4 June 2026.

On the market, this insider has only sold: 2 sales, €281k in total. Besides market trades, the filings include 5 share grants and 1 option exercise.

The newest entry dates from 5 June 2026: a share grant, in Sarepta Therapeutics, Inc. Typically, a trade is published a median of 1 day after it takes place. Section 16 rules allow two business days to file each Form 4. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.